Hormonal Comparison

Ipamorelin vs CJC-1295

Comparison of two growth hormone-releasing peptides with different mechanisms and duration profiles.

Last updated: January 19, 2026

Ipamorelin

Moderate Evidence
View full dossier

CJC-1295

Moderate Evidence
View full dossier

Overview

Ipamorelin and CJC-1295 work through different receptor systems to stimulate growth hormone release. They are sometimes used in combination but neither is FDA-approved.

Mechanism Comparison

AspectIpamorelinCJC-1295
Receptor TargetGhrelin/GHSRGHRH receptor
MechanismGH secretagogueGHRH analog
Natural AnalogGhrelin-likeGHRH-like

Selectivity Profile

EffectIpamorelinCJC-1295
GH ReleaseYesYes
Cortisol EffectMinimalMinimal
Prolactin EffectMinimalMinimal
Appetite StimulationLess than GHRP-6Minimal

Duration of Action

ParameterIpamorelinCJC-1295 DACCJC-1295 no DAC
Half-life~2 hours5-8 days~30 minutes
GH PatternPulsatileSustainedPulsatile

Evidence Quality

AspectIpamorelinCJC-1295
Human TrialsPhase 1/2 completedLimited Phase 1
Development StatusDiscontinuedDiscontinued
Evidence LevelModerateModerate

Combined Use

These peptides are sometimes used together, theoretically for synergistic GH release. However:

  • No clinical trials of combination
  • Safety not established
  • Efficacy unproven

Regulatory Status

Both peptides:

  • Are not FDA approved
  • Are prohibited by WADA
  • Have discontinued pharmaceutical development
  • Are available only through unregulated sources

Summary

FactorIpamorelinCJC-1295
Best forSelective GH releaseSustained GH elevation (DAC)
SelectivityHighN/A (different mechanism)
Human dataMore availableLess available
Approval statusNot approvedNot approved

This comparison is for educational purposes only. Neither peptide is approved by regulatory agencies.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.